Insights

President Donald Trump confirmed this week that his administration is actively reviewing the possibility of reclassifying marijuana as a less dangerous drug. This move would follow through on a... Read More >

In a major legal win for New York cannabis licensees, Mandelbaum Barrett PC has secured a precedent-setting decision that strengthens the rights of businesses facing Office of Cannabis Management... Read More >

Joshua S. Bauchner, Chair of the Cannabis, Hemp, and Psychedelics Practice Group at Mandelbaum Barrett PC, recently appeared on Blunt Business hosted by Cannabis Radio. In this episode, he unpacked... Read More >

On July 28, 2025, the New York State Office of Cannabis Management (OCM) confirmed what many in the cannabis industry have long suspected: inconsistent enforcement and interpretation of its own... Read More >

Joshua S. Bauchner, Chair of the Cannabis, Hemp & Psychedelics Practice Group at Mandelbaum Barrett PC, recently explored a pivotal federal court ruling in his latest article for the New Jersey Law... Read More >

Joshua S. Bauchner, Chair of the Cannabis, Hemp, and Psychedelics Practice Group at Mandelbaum Barrett PC, was recently highlighted in the New Jersey Business Magazine article titled “Cannabis... Read More >

The cannabis industry in New Jersey is undergoing a transformation, with an increased emphasis on safety, transparency, and quality assurance. During its February 18th public meeting, the New Jersey... Read More >

New Jersey lawmakers are considering a bill that could significantly impact the cannabis industry by simplifying the approval process for medical dispensaries to sell adult-use cannabis. Currently,... Read More >

Our Spring 2025 Newsletter covers the latest in cannabis, hemp, and psychedelics!  Check out some of the topics we cover in our latest issue: – Kicking Off 2025 with More... Read More >